What is it about?
This article describes the clinical presentation and the outcome of the pandemic 2009 H1N1 Influenza among patients with cancer or stem cell transplantation.
Featured Image
Why is it important?
it is important because in cancer patients and in patients who received a transplantation, the infections are usually more severe than in the general population. This is the reason why cancer and transplant patients should receive the vaccine against the flu or Influenza.
Perspectives
It is important to see that in Argentina, the pandemic 2009 H1N1 Influenza virus caused severe disease in cancer and transplant patients in Argentina. These results are different than those observed in the Northern Hemisphere. In addition, this article indirectly describes a protection given by the seasonal flu vaccination. Therefore, this is another reason to keep recommending influenza vaccination in cancer and transplant patients.
MD Maria Cecilia Dignani
REMIIN (Registro Micosis Invasoras)
Pandemic influenza showed in cancer patients a high incidence of pneumonia and mortality. Even though all guidelines recommend flu vaccine in cancer patients only 30% of the patients had been vaccinated. It makes extremely important that oncologist, hematologists and other doctors that deal with oncology patients are aware of the importance of this infection and the need to recommend the vaccine to all their patients.
Dr Patricia E Costantini
Instituto de Oncologia Angel H Roffo University of Buenos Aires
Read the Original
This page is a summary of: Pandemic 2009 Influenza A (H1N1) virus infection in cancer and hematopoietic stem cell transplant recipients; a multicenter observational study., F1000Research, September 2014, Faculty of 1000, Ltd.,
DOI: 10.12688/f1000research.5251.1.
You can read the full text:
Contributors
The following have contributed to this page
